<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0400">
 <label>80</label>
 <element-citation publication-type="book" id="sbref0400">
  <chapter-title>Research C for BE and. Revised information for investigational COVID-19 convalescent plasma</chapter-title>
  <year>2020</year>
  <publisher-name>FDA</publisher-name>
  <comment>(Accessed April 7, 2020)</comment>
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/revised-information-investigational-covid-19-convalescent-plasma" id="intr0065" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/revised-information-investigational-covid-19-convalescent-plasma</ext-link>
 </element-citation>
</ref>
